Cytokines, such as interferon-gamma have been shown to have adjuvant and gr
owth promoting activity in poultry and livestock and have the potential to
be used as alternatives to antibiotics. We have developed an efficient syst
em for commercial-scale synthesis of recombinant chicken interferon-gamma (
ChIFN-gamma) using Brevibacillus choshinensis as the host for protein produ
ction. The ChIFN-gamma expression vector, pNCIFN, was constructed using the
novel Escherichia coli-B. choshinensis shuttle vector, pNCMO2. ChIFN-gamma
expression was optimized by investigating different culture conditions and
different host B. choshinensis mutants. The highest level of production wa
s observed using the B. choshinensis HPD31-MB2 strain grown at 30 degreesC,
where ChIFN-gamma was produced at approximately 300-500 mg/ L. ChIFN-gamma
was also produced as a His-tagged fusion protein by using the pNCHis-IFN e
xpression vector, a derivative of pNCMO2. The protein was constitutively se
creted into the culture supernatant and could be partially purified in a si
ngle step using a Ni-nitrilotriacetic acid column. This recombinant His-ChI
FN-gamma was shown to have the same biological activity as native ChIFN-gam
ma. (C) 2001 Academic Press.